StreetAlpha.app
Home › Stocks › HYFT

MindWalk Holdings Corp. (HYFT)

Healthcare
$0.68
▼ −14.27%
LAST CLOSE · NOV 20

MindWalk Holdings provides AI tools and laboratory services for drug discovery to pharmaceutical and biotech companies. It last closed at $0.68 on Nov 20, down 14.27% on the day.

AI Auto Pilots
Is HYFT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HYFT.

Key Stats

Last 12 months
Results
Revenue
CAD 28.1M
+95.9% vs a year ago
Net income
−CAD 12.2M
−43.6% margin
Free cash flow
−CAD 11.9M
−42.5% margin
Gross margin
57.2%
CAD 16.1M gross profit
Balance sheet
Cash & equivalents
CAD 14.2M
At Jan 31
Shareholder equity
CAD 14.9M
Fiscal year endsApril
ExchangeNasdaq
Financials history
FY2021: CAD 17.9MCAD 17.9MFY2021FY2022: CAD 19.4MCAD 19.4MFY2022FY2023: CAD 20.7MCAD 20.7MFY2023FY2024: CAD 24.5MCAD 24.5MFY2024FY2025: CAD 24.5MCAD 24.5MFY2025

From HYFT's SEC filings, latest 20-F for the period ending Jan 31, 2026 (filed Jul 23). Last 12 months adds up the four latest quarters. Figures are in CAD. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on file yet
Reported EPS
—
Quarter ended Jan 2026
Year ago EPS
—
Same quarter last year
Revenue
$4.2M
+52.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Not enough quarters on file yet.
Revenue by quarter
Apr 2024: $6.5MApr '24Jul 2024: $2.5MJul '24Oct 2024: $2.7MOct '24Jan 2025: $2.7MJan '25Apr 2025: $16.6MApr '25Jul 2025: $3.2MJul '25Oct 2025: $4.1MOct '25Jan 2026: $4.2MJan '26Latest $4.2M
StreetAlpha's call on HYFTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on HYFT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on HYFT

Technical Analysis

HYFT · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 50% below its 20 day and 79% below its 50 day average. It is 94% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 18), oversold. The nearest support is the 52 week low at $0.64, and the nearest resistance the Pivot at $0.71.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 15.3%/day
Key levels
$2.9952 week high+339.7%
$1.33200 day average+95.6%
$1.30100 day average+91.2%
$1.27Swing high (Oct 29)+86.8%
$1.2250 day average+79.4%
$1.0220 day average+50.0%
$0.78Pivot R1+14.7%
$0.71Pivot+4.4%
$0.68Last close
$0.6452 week low−5.9%
$0.62Pivot S1−8.8%
Indicators
RSI (14)18.42Oversold below 30Oversold
MACD-0.12Below its signal lineBearish
Stochastic7.9Near the bottom of its rangeOversold
ADX (14)30.1Trending down
Williams %R-91.9Oversold below −80, overbought above −20Oversold
CCI (20)-223.7Oversold below −100, overbought above 100Oversold
Rate of change−35.4%Change over 10 sessionsBearish
ATR (14)$0.10Typical daily range, 15.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for HYFT

What happened before

See how HYFT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow HYFT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How HYFT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for HYFTHow many large options trades hit HYFT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

HYFT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●11 buying vs 11 selling
  • ●Held by funds +0.1 pts
  • ▼Funds holding -1
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2627−3.7%
In funds' top 1000–
Held by funds9.5%9.3%+0.1 pts
New / increased3 / 85 / 60.0%
Reduced / sold out7 / 46 / 4+10.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HYFT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HYFT is in one of them and how their past HYFT trades turned out.

HYFT in the AI portfolios
Loading…

HYFT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HYFT in an article yet. Here's the latest on the wider market.

HYFT in the news

About MindWalk Holdings

MindWalk Holdings is an AI company based in Austin, Texas that applies artificial intelligence and laboratory work to drug discovery. Its LensAI software and ReefIQ data layer help life sciences companies analyze biological data and connect it to AI models. Clients can access the platform through projects, software subscriptions and integrations, and the company also develops its own antibody and vaccine candidates. Its customers are mainly pharmaceutical and biotech companies, served directly and through Talem, a unit that offers partnerships.

Headquarters
Victoria
Founded
1983